Innovation Pharmaceuticals Inc (IPIX)

[bradfordbros]

If the market knew that Kevetrin in Phase 1 has proven both efficacy and safety the stock would be much higher. We are waiting for confirmation. Dana Farber's Dr Shapiro saying it is what we want to hear.

There is much more to come on Brilacidin Phase 3 and the same with Kevetrin Phase 2 ovarian cancer.

Infact if you look at the progression of all the trials CTIX has put together everyone of them has been a success. In other words we are looking at a major success story which can only transmit into a higher SP.

PS The company has already stated they want to be another Regeneron which to me means $$$$$ from many BPs.